Go Back

Company or ticker...

BioTech

argenx

Argenx is develops new antibody-based medicines to treat serious autoimmune diseases and cancer.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ARGX

59.4B

8.2

36.3

13.33%

Key Facts

M. Cap

PS

PE

YTD

59.4B

8.2

36.3

13.33%

10MA

20MA

50MA

200MA

$ARGX

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now